Pulse Biosciences, Inc. (NasdaqCM: PLSE)
Health Care · Health Care Equipment & Supplies · US
$48.10
-4.60% today · +205.8% 1Y
Pulse Biosciences, Inc. (NasdaqCM: PLSE) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $3.60B and employs 116 people.
Over the last twelve months the share price has gained 205.8%, trading between 12.56 and 50.71.
Tweenvest scores Pulse Biosciences, Inc. across four factors: quality 27/100. Its strongest factor is quality.
PLSE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.60B
- Revenue (TTM)
- $1.19M
- P/E
- —
- EPS
- -1.18
- Dividend yield
- —
- Beta (5Y)
- 1.58
- 52-week high
- $50.71
- 52-week low
- $12.56
- Avg volume (3M)
- —
- Shares outstanding
- 71.32M
- Employees
- 116
- Next earnings
- —
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
- ISIN
- US74587B1017
- Founded
- 2014
- Listed since
- May 18, 2016
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $114.10 | -1.75% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $370.42 | -0.38% |
| Stryker CorporationNYSE: SYK | $126.81B | $329.67 | -0.28% |
| Medtronic plcNYSE: MDT | $116.66B | $92.02 | +0.97% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.20 | +0.03% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $48.17 | -3.39% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.78 | -0.10% |
Figures last refreshed Aug 18, 2026.